K. Bartels

发表

Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients

C. Bokemeyer, J. Panse, K. Friedrichs, 2008, British Journal of Cancer.

Cancer‐testis antigen expression and its epigenetic modulation in acute myeloid leukemia

C. Bokemeyer, Y. Hildebrandt, T. Luetkens, 2011, American journal of hematology.

The Local Cytokine and Chemokine Milieu within Malignant Effusions

C. Bokemeyer, Y. Hildebrandt, K. Bartels, 2008, Tumor Biology.

Antigen Expression in Multiple Myeloma Longitudinal Analysis and Prognostic Effect of Cancer-Testis

C. Bokemeyer, Y. Hildebrandt, T. Luetkens, 2009 .

The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting

C. Bokemeyer, Y. Hildebrandt, T. Luetkens, 2013, Human vaccines & immunotherapeutics.

accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation

C. Bokemeyer, J. Panse, T. Luetkens, 2008 .

NY‐CO‐58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer

C. Bokemeyer, K. Friedrichs, A. Marx, 2010, International journal of cancer.

Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia.

C. Bokemeyer, T. Brümmendorf, Y. Hildebrandt, 2010, Leukemia research.

Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma

C. Bokemeyer, K. Bartels, S. Wenzel, 2006, Cancer biology & therapy.

Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.

C. Bokemeyer, K. Bartels, N. Kröger, 2007, Blood.

An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body.

C. Bokemeyer, Y. Hildebrandt, T. Luetkens, 2010, Journal of immunological methods.

Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma

T. Luetkens, K. Bartels, N. Kröger, 2015, Journal of Translational Medicine.

induce systemic immunity following allogeneic stem cell transplantation Cancer-testis antigens are commonly expressed in multiple myeloma and

K. Bartels, N. Kröger, J. Dierlamm, 2013 .

Peripheral T cells of patients with B cell non-Hodgkin's lymphoma show a shift in their memory status.

J. Panse, K. Bartels, D. Atanackovic, 2005, Leukemia research.

The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients.

C. Bokemeyer, Y. Hildebrandt, T. Luetkens, 2010, Experimental hematology.

T‐Cell Survival Regulator LKLF Is Not Involved in Inappropriate Apoptosis of Diabetes‐Prone BBDP Rat T Cells

K. Bartels, F. Koch-Nolte, F. Haag, 2003, Annals of the New York Academy of Sciences.

Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma

C. Bokemeyer, J. Panse, A. Marx, 2011, Haematologica.

CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation

C. Bokemeyer, J. Panse, T. Luetkens, 2008, Haematologica.

Longitudinal Analysis of Tetanus- and Influenza-Specific IgG Antibodies in Myeloma Patients

C. Bokemeyer, Y. Hildebrandt, T. Luetkens, 2012, Clinical & developmental immunology.

Cancer‐testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma

Y. Hildebrandt, T. Luetkens, K. Bartels, 2015, British journal of haematology.

Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation

C. Bokemeyer, A. Marx, Y. Hildebrandt, 2014, Cancer Immunology, Immunotherapy.

Acute psychological stress alerts the adaptive immune response: Stress-induced mobilization of effector T cells

C. Bokemeyer, K. Bartels, D. Atanackovic, 2006, Journal of Neuroimmunology.

Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells

C. Bokemeyer, Y. Hildebrandt, T. Luetkens, 2010, Haematologica.

Longitudinal Analysis and Prognostic Effect of Cancer-Testis Antigen Expression in Multiple Myeloma

C. Bokemeyer, Y. Hildebrandt, T. Luetkens, 2009, Clinical Cancer Research.

Decrease of CD4+FOXP3+ T regulatory cells in the peripheral blood of human subjects undergoing a mental stressor

C. Bokemeyer, Y. Hildebrandt, T. Luetkens, 2010, Psychoneuroendocrinology.

Expression of Cancer-Testis Antigens MAGE-C1/CT7 and MAGE-A3 Is Central to the Survival of Myeloma Cells and Their Resistance to Chemotherapy

C. Bokemeyer, Y. Hildebrandt, T. Luetkens, 2008 .

Clinical Study Patients withMultiple Myeloma Develop SOX 2-Specific Autoantibodies after Allogeneic Stem Cell Transplantation

C. Bokemeyer, A. Marx, Y. Hildebrandt, 2014 .

Patients with Multiple Myeloma Develop SOX2-Specific Autoantibodies after Allogeneic Stem Cell Transplantation

C. Bokemeyer, A. Marx, Y. Hildebrandt, 2011, Clinical & developmental immunology.

Acute psychological stress increases peripheral blood CD3+CD56+ natural killer T cells in healthy men: possible implications for the development and treatment of allergic and autoimmune disorders

C. Bokemeyer, Y. Hildebrandt, K. Bartels, 2013, Stress.

Role of interleukin 16 in multiple myeloma.

C. Bokemeyer, J. Panse, A. Marx, 2012, Journal of the National Cancer Institute.

A local enrichment of regulatory T cells within the tumor tissue might suppress an effective anti-tumor T cell response in patients with head and neck cancer

K. Bartels, R. Leuwer, D. Atanackovic, 2005 .

CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation

C. Bokemeyer, J. Panse, T. Luetkens, 2008, Haematologica.